AUTHOR=Zhang Hui , Li Yueyun , Liu Yuhang , Li Haonan , Wang Hong 

TITLE=Cost-effectiveness analyses of amivantamab plus lazertinib and lazertinib versus osimertinib in non-small cell lung cancer with EGFR mutations

JOURNAL=Frontiers in Pharmacology

VOLUME=Volume 16 - 2025

YEAR=2025

URL=https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1527614

DOI=10.3389/fphar.2025.1527614

ISSN=1663-9812